- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
45
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
45 companies
Indivior
Market Cap: US$4.1b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
US$33.54
7D
2.0%
1Y
181.1%
China Resources Pharmaceutical Group
Market Cap: HK$28.6b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.56
7D
-1.3%
1Y
-10.6%
Hypera
Market Cap: R$15.6b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$25.16
7D
6.5%
1Y
37.2%
Lotus Pharmaceutical
Market Cap: NT$82.6b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$314.00
7D
-1.4%
1Y
21.7%
Organon
Market Cap: US$2.5b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$9.74
7D
12.0%
1Y
-40.6%
Bausch Health Companies
Market Cap: US$2.5b
Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
BHC
US$6.57
7D
-9.5%
1Y
-15.9%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥15.5b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥9.57
7D
0.7%
1Y
-27.3%
Harmony Biosciences Holdings
Market Cap: US$2.1b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$36.76
7D
1.0%
1Y
-3.3%
Bora Pharmaceuticals
Market Cap: NT$63.6b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$513.00
7D
-2.5%
1Y
-23.4%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥13.2b
Engages in research, development, production, and sales of blood products in China and internationally.
000403
CN¥13.94
7D
-2.9%
1Y
-16.2%
Vitrolife
Market Cap: SEK 17.1b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 126.50
7D
-3.7%
1Y
-40.2%
Alvotech
Market Cap: US$1.6b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$5.17
7D
4.4%
1Y
-60.6%
Collegium Pharmaceutical
Market Cap: US$1.5b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$47.10
7D
0.4%
1Y
47.9%
Shanghai Haohai Biological Technology
Market Cap: HK$10.8b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$25.50
7D
-1.7%
1Y
3.7%
Genomma Lab Internacional. de
Market Cap: Mex$17.2b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$17.51
7D
0.06%
1Y
-37.0%
L&C BIOLTD
Market Cap: ₩1.3t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩54,000.00
7D
-2.5%
1Y
134.8%
Strides Pharma Science
Market Cap: ₹79.7b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹864.60
7D
-8.0%
1Y
37.6%
Tong Ren Tang Technologies
Market Cap: HK$5.6b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.37
7D
-2.2%
1Y
-9.5%
Emergent BioSolutions
Market Cap: US$604.0m
A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.
EBS
US$12.09
7D
10.4%
1Y
5.3%
Shilpa Medicare
Market Cap: ₹52.9b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.
530549
₹270.65
7D
-8.0%
1Y
-33.6%
Medy-Tox
Market Cap: ₩842.4b
Operates as a biopharmaceutical company in South Korea.
A086900
₩120,000.00
7D
0.3%
1Y
-1.0%
Newron Pharmaceuticals
Market Cap: CHF 453.3m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 22.65
7D
-10.5%
1Y
142.2%
Zevra Therapeutics
Market Cap: US$508.4m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$9.08
7D
0.7%
1Y
12.1%
DongKook Pharmaceutical
Market Cap: ₩742.2b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩16,590.00
7D
0.06%
1Y
10.1%
SIGA Technologies
Market Cap: US$476.9m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.73
7D
1.8%
1Y
4.0%
Dong-A Socio Holdings
Market Cap: ₩674.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩104,800.00
7D
1.6%
1Y
11.9%
Clinuvel Pharmaceuticals
Market Cap: AU$607.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$12.18
7D
-4.0%
1Y
2.9%
Beximco Pharmaceuticals
Market Cap: ৳50.5b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳113.30
7D
7.9%
1Y
47.5%
Blau Farmacêutica
Market Cap: R$2.1b
A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$9.49
7D
5.3%
1Y
-1.8%
Orchid Pharma
Market Cap: ₹35.8b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹705.10
7D
-5.0%
1Y
-54.1%
Essex Bio-Technology
Market Cap: HK$2.3b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.11
7D
-6.2%
1Y
46.3%
JBM (Healthcare)
Market Cap: HK$2.3b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.76
7D
-0.7%
1Y
53.3%
Abeona Therapeutics
Market Cap: US$287.8m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.36
7D
-1.7%
1Y
2.1%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م13.2b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م78.25
7D
2.5%
1Y
70.7%
IOL Chemicals and Pharmaceuticals
Market Cap: ₹21.1b
Manufactures and sells pharmaceutical and chemical products in India and internationally.
524164
₹72.01
7D
-4.7%
1Y
-7.0%
Coherus Oncology
Market Cap: US$198.2m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.59
7D
-4.2%
1Y
24.2%